StockWatch
·
Medical/Dental Instruments
Corporate GovernanceJun 12, 2026, 05:26 PM

Tenon Medical Increases Executive Salaries, Bonuses; Extends Ferrari's Term

AI Summary

Tenon Medical, Inc. announced its 2026 Executive Compensation Plan, effective March 1, 2026, which includes a 5% increase in annual base salaries for its CEO, CFO, and COO. The plan also revised annual bonus opportunities and introduced a second bonus for these executives based on milestone achievements. Additionally, the company extended Executive Chairman Richard Ferrari's consulting agreement for another year, maintaining his compensation at $45,000 per quarter.

Key Highlights

  • Tenon Medical approved its 2026 Executive Compensation Plan, effective March 1, 2026.
  • CEO Steven M. Foster's annual base salary increased by 5% to $420,000.
  • CFO Kevin Williamson's annual base salary increased by 5% to $330,750.
  • COO Richard Ginn's annual base salary increased by 5% to $304,500.
  • Mr. Foster's annual bonus opportunity changed to 50% of base salary.
  • Mr. Williamson and Mr. Ginn's annual bonus opportunity changed to 35% of base salary.
  • A second bonus of up to $100,000 for Mr. Foster, $70,000 for Mr. Williamson, and $50,000 for Mr. Ginn was approved.
  • Richard Ferrari's consulting agreement was extended for one year, from May 7, 2026, to May 6, 2027, with quarterly compensation of $45,000 ($180,000 annually).